home / stock / prn:cc / prn:cc news


PRN:CC News and Press, Profound Medical Corp. From 03/06/26

Stock Information

Company Name: Profound Medical Corp.
Stock Symbol: PRN:CC
Market: TSXC
Website: profoundmedical.com

Menu

PRN:CC PRN:CC Quote PRN:CC Short PRN:CC News PRN:CC Articles PRN:CC Message Board
Get PRN:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

PRN:CC - Profound Medical outlines path to $85M revenue and profitable growth with TULSA expansion in 2026

2026-03-06 01:16:40 ET More on Profound Medical Corp. Profound Medical Corp. (PRN:CA) Q4 2025 Earnings Call Transcript Profound Medical announces pricing of up to $40 million financing Seeking Alpha’s Quant Rating on Profound Medical Corp. Historical e...

PRN:CC - Profound Medical GAAP EPS of $0.27 beats by $0.55, revenue of $6M misses by $1.72M

2026-03-05 16:29:51 ET More on Profound Medical Corp. Profound Medical announces pricing of up to $40 million financing Seeking Alpha’s Quant Rating on Profound Medical Corp. Historical earnings data for Profound Medical Corp. Financial information for...

PRN:CC - Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results

TORONTO, March 05, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, today reporte...

PRN:CC - Expected Canadian Company Earnings on Thursday, March 5th, 2026

HealWELL AI Inc. Class A Subordinate Voting Shares (AIDX:CA) is expected to report $-0.03 for Q4 2025 Parkit Enterprise Inc. (PKT:CA) is expected to report $0.01 for Q4 2025 Profound Medical Corp. (PRN:CA) is expected to report $-0.38 for Q4 2025 AbraSilver Resource Corp. (ABRA:CA) is...

PRN:CC - Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th - Conference Call to Follow

TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, will announce its fourth quart...

PRN:CC - Profound Medical Honored with INOVAIT's 2025-2026 Mount Logan Award Recognizing the TULSA Procedure(TM) for Prostate Disease

TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage innovator in interventional MRI (“iMRI”) procedures, is pleased to announce that it has received the 2025/2026 Mou...

PRN:CC - PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women's Health

TORONTO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased ...

PRN:CC - Opinion: This Is the Only TSX Growth Stock to Own for the Next 3 Years

2026-02-01 20:15:00 ET Investing in quality growth stocks is a great strategy for generating outsized returns over the long term. Valued at a market cap of less than $400 million, Profound Medical ( TSX:PRN ) is a commercial-stage medical device company that is poised to grow at...

PRN:CC - Profound Medical Announces Upcoming Investor Events

TORONTO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased ti...

PRN:CC - Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®

Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked No. 6 nationally for Urology by US News & World Report ® for 2025-26 TORONTO, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Profound Medical...

Previous 10 Next 10